Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Thymoma 1Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Small Cell Lung Carcinoma 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Malignant Solid Tumor 1

Interventions

pembrolizumab 6Nivolumab 3tislelizumab 2budigalimab 2Ipilimumab 2Depsipeptides 2Decitabine 2venetoclax 1talazoparib 1spartalizumab 1sargramostim 1rovalpituzumab tesirine 1regorafenib 1poly ICLC 1iodixanol 1epacadostat 1entinostat 1durvalumab 1cemiplimab 1avelumab 1atezolizumab 1alvocidib 1Tomography, Optical Coherence 1Tissue Banks 1Tablets 1Radiosurgery 1Radiofrequency Ablation 1Paclitaxel 1Iohexol 1Interferon-gamma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × Radiofrequency Ablation × Other solid neoplasm × Clear all
NCT00024076 2020-08-03

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Jonsson Comprehensive Cancer Center

Phase 2 Completed
30 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Thymoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡